BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Mainstay Medical Announces Positive Outcome of Interim Analysis

  Mainstay Medical announces a positive outcome of the Interim Analysis in its U.S. Pivotal ReActiv8-B Study, comprising a definitive size and an estimated completion date.

  December 11, 2017

   · 

  4 min read
• Business

  STORM Therapeutics Announces Appointments to Scientific Advisory Board

  These appointments will strengthen STORM’s advisory networks as it fulfils its ambition to become the leading therapeutics company in RNA epigenetic modulation.

  December 11, 2017

   · 

  1 min read
• HeartStitch Leading the Growth of PFO Closure in Italy

  Kardia announced expansion plan of the NobleStitch EL at a recent meeting organized by Professor Francesco Romeo at Policlinico Tor Vergata in Rome where Prof. Achille Gaspardone performed a successful NobleStitch™ EL live case that was transmitted to the attendees in Ayla Magna, Rome, Italy.

  December 11, 2017

   · 

  6 min read
• Business

  Leading Biotech Immunocore Expands to the Oxford Science Park

  Immunocore Limited, the world’s leading TCR company focused on delivering first-in-class biological therapies that transform lives, has taken laboratory and office space at The Oxford Science Park.

  December 11, 2017

   · 

  1 min read
• Business

  Adesis Grows Business and Expands Its Fundamental Chemistry Capabilities in Delaware

  Adesis announced that it will open a new suite of state-of-the-art laboratories in Delaware and expand its organic chemistry team and R&D programs.

  December 11, 2017

   · 

  7 min read
• Business

  AngioDynamics to Report Fiscal 2018 Second Quarter Financial Results on January 4, 2018

  AngioDynamics announced that it will report financial results for the second quarter of fiscal year 2018 before the market open on Thursday, January 4, 2018.

  December 11, 2017

   · 

  1 min read
• Aurinia Pharmaceuticals Added to the NASDAQ Biotech Index

  Additionally, Aurinia was recently added to the MSCI Global Small Cap Indexes, which went into effect at close of November 30, 2017.

  December 11, 2017

   · 

  1 min read
• Genetown

  bluebird bio Announces Proposed of $600 Million of Public Offering of Common Stock

  bluebird bio also intends to grant the underwriters a 30-day option to purchase up to an additional fifteen percent (15%) of the shares of common stock offered in the public offering.

  December 11, 2017

   · 

  5 min read
• Deals

  Odonate Therapeutics Announces Closing of Initial Public Offering of 6,250,000 Shares of Common Stock

  Odonate Therapeutics announced the closing of its initial public offering of 6,250,000 shares of common stock at a public offering price of $24.00 per share.

  December 11, 2017

   · 

  2 min read
• Pharm Country

  Zoetis Declares First Quarter 2018 Dividend; Board Approves 20% Payment Increase

  The dividend is to be paid on Thursday, March 1, 2018, to holders of record on Friday, January 19, 2018.

  December 11, 2017

   · 

  2 min read